# Classification Categories for Certain Supplements Under BsUFA III - FDA Guidance Document

Source: https://www.keypedia.com/guidances/guidance-document/classification-categories-for-certain-supplements-under-bsufa-iii/66d51a68-e6a8-4e86-8097-7ddf219d36b9

> FDA guidance document: Classification Categories for Certain Supplements Under BsUFA III. Issue date: September 08, 2025. Get complete insights and analysis.

---

## Details

- Title: Classification Categories for Certain Supplements Under BsUFA III
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2025-09-08
- Comment Close Date: 2023-10-10
- Last Changed: 2025-09-08
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2023-D-1954">FDA-2023-D-1954</a>

## Related Documents

- [Bioanalytical Method Validation for Biomarkers](https://www.keypedia.com/guidances/guidance-document/bioanalytical-method-validation-for-biomarkers/dc48cea7-abd8-44db-a6fc-14b002aa59d7)
- [E6(R3) Good Clinical Practice (GCP)](https://www.keypedia.com/guidances/guidance-document/e6r3-good-clinical-practice-gcp/682dfcf6-82b9-407c-9ffb-89c51a0a4944)
- [Development of Therapeutic Protein Biosimilars:  Comparative Analytical Assessment and Other Quality-Related Considerations   Guidance for Industry](https://www.keypedia.com/guidances/guidance-document/development-of-therapeutic-protein-biosimilars-comparative-analytical-assessment-and-other-quality-related-considerations-guidance-for-industry/07142307-dadf-4c95-927c-469f261c1c58)